(Q74305688)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483268%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

A randomised comparison of two inactivated hepatitis A vaccines, Avaxim and Vaqta, given as a booster to subjects primed with Avaxim (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483268%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

1 reference

P Clarke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483268%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

N Kitchin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483268%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

F Souverbie

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483268%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483268%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483268%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483268%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483268%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

4429-4433

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483268%20AND%20SRC:MED&resulttype=core&format=json

Risk of hepatitis A in travellers

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900195-5

7 January 2021

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900195-5

7 January 2021

Protection against hepatitis A by an inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900195-5

7 January 2021

Clinical development of a new inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900195-5

7 January 2021

Immunogenicity and reactogenicity of Avaxim (160 AU) as compared with Havrix (1440 EL.U) as a booster following primary immunization with Havrix (1440 EL.U) against hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900195-5

7 January 2021

Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900195-5

7 January 2021

Sensitive assays for hepatitis A antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900195-5

7 January 2021

Comparative immunogenicity and tolerance of Vaqta and Havrix

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900195-5

7 January 2021

Immunogenicity and safety of a new inactivated hepatitis A vaccine in a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900195-5

7 January 2021

10.1016/S0264-410X(01)00195-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11483268%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference